Literature DB >> 20826760

HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin.

Arnaud Friggeri1, Yanping Yang, Sami Banerjee, Yong-Jun Park, Gang Liu, Edward Abraham.   

Abstract

Phagocytosis of apoptotic cells is critical to resolution of inflammation. High mobility group box 1 protein (HMGB1), a mediator of inflammation, has been shown to diminish phagocytosis through binding to phosphatidylserine (PS) exposed on the surface of apoptotic neutrophils. However, it is currently unknown whether HMGB1 also modulates the activity of receptors involved in PS recognition on the surface of phagocytes. In the present studies, we found that preincubation of macrophages with HMGB1 decreased their ability to engulf apoptotic neutrophils or thymocytes. Preincubation of macrophages with HMGB1 prevented the enhancement of efferocytosis resulting from exposure to milk fat globule EGF factor 8 (MFG-E8), an opsonin that bridges PS and α(v)β(3) as well as α(v)β(5)-integrins on the surface of phagocytes. The inhibitory effect of HMGB1 on the phagocytic activity of macrophages was prevented by preincubation of HMGB1 with soluble α(v)β(3), but not with soluble α(v)β(5). HMGB1 colocalized with the β(3)-integrin on the cell membrane of macrophages and bound to soluble α(v)β(3), but not to soluble α(v)β(5). HMGB1 suppressed the interaction between MFG-E8 and α(v)β(3). HMGB1 also inhibited intracellular signaling events, including ERK phosphorylation and Rac-1 activation, which are activated in macrophages during phagocytosis of apoptotic cells. These results demonstrate that HMGB1 blocks α(v)β(3)-dependent recognition and uptake of apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826760      PMCID: PMC3006331          DOI: 10.1152/ajpcell.00152.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  44 in total

Review 1.  Phosphatidylserine recognition by phagocytes: a view to a kill.

Authors:  Yi Wu; Nitu Tibrewal; Raymond B Birge
Journal:  Trends Cell Biol       Date:  2006-03-10       Impact factor: 20.808

Review 2.  Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease.

Authors:  R William Vandivier; Peter M Henson; Ivor S Douglas
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

3.  Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin).

Authors:  Ari Rouhiainen; Sarka Tumova; Leena Valmu; Nisse Kalkkinen; Heikki Rauvala
Journal:  J Leukoc Biol       Date:  2006-09-15       Impact factor: 4.962

4.  A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.

Authors:  Valeria V Orlova; Eun Young Choi; Changping Xie; Emmanouil Chavakis; Angelika Bierhaus; Eveliina Ihanus; Christie M Ballantyne; Carl G Gahmberg; Marco E Bianchi; Peter P Nawroth; Triantafyllos Chavakis
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

5.  Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.

Authors:  Derek C Angus; Lihong Yang; Lan Kong; John A Kellum; Russell L Delude; Kevin J Tracey; Lisa Weissfeld
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

6.  HMGB1 contributes to the development of acute lung injury after hemorrhage.

Authors:  Jae Yeol Kim; Jong Sung Park; Derek Strassheim; Ivor Douglas; Fernando Diaz del Valle; Karim Asehnoune; Sanchayita Mitra; Sang Hyun Kwak; Shingo Yamada; Ikuro Maruyama; Akitoshi Ishizaka; Edward Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-01-07       Impact factor: 5.464

7.  Involvement of vitronectin in lipopolysaccaride-induced acute lung injury.

Authors:  Yuko Tsuruta; Young-Jun Park; Gene P Siegal; Gang Liu; Edward Abraham
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 8.  MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure.

Authors:  Rikinari Hanayama; Kay Miyasaka; Michio Nakaya; Shigekazu Nagata
Journal:  Curr Dir Autoimmun       Date:  2006

Review 9.  Journey to the grave: signaling events regulating removal of apoptotic cells.

Authors:  Jason M Kinchen; Kodi S Ravichandran
Journal:  J Cell Sci       Date:  2007-07-01       Impact factor: 5.285

10.  Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.

Authors:  Jane Tian; Ana Maria Avalos; Su-Yau Mao; Bo Chen; Kannaki Senthil; Herren Wu; Peggy Parroche; Stacey Drabic; Douglas Golenbock; Cherilyn Sirois; Jing Hua; Ling Ling An; Laurent Audoly; Greg La Rosa; Angelika Bierhaus; Peter Naworth; Ann Marshak-Rothstein; Mary K Crow; Katherine A Fitzgerald; Eicke Latz; Peter A Kiener; Anthony J Coyle
Journal:  Nat Immunol       Date:  2007-04-08       Impact factor: 25.606

View more
  58 in total

1.  Intracellular HMGB1 negatively regulates efferocytosis.

Authors:  Sami Banerjee; Andressa de Freitas; Arnaud Friggeri; Jaroslaw W Zmijewski; Gang Liu; Edward Abraham
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 2.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

Review 3.  Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling.

Authors:  Philip J Vernon; Daolin Tang
Journal:  Antioxid Redox Signal       Date:  2012-09-18       Impact factor: 8.401

4.  AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils.

Authors:  Hong-Beom Bae; Jaroslaw W Zmijewski; Jessy S Deshane; Jean-Marc Tadie; David D Chaplin; Seiji Takashima; Edward Abraham
Journal:  FASEB J       Date:  2011-09-01       Impact factor: 5.191

Review 5.  From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins.

Authors:  Ioannis Kourtzelis; Ioannis Mitroulis; Janusz von Renesse; George Hajishengallis; Triantafyllos Chavakis
Journal:  J Leukoc Biol       Date:  2017-03-14       Impact factor: 4.962

Review 6.  Neutrophils as protagonists and targets in chronic inflammation.

Authors:  Oliver Soehnlein; Sabine Steffens; Andrés Hidalgo; Christian Weber
Journal:  Nat Rev Immunol       Date:  2017-03-13       Impact factor: 53.106

7.  Aged Human Stored Red Blood Cell Supernatant Inhibits Macrophage Phagocytosis in an HMGB1 Dependent Manner After Trauma in a Murine Model.

Authors:  Kent R Zettel; Mitchell Dyer; Jay S Raval; Xubo Wu; John R Klune; Andres Gutierrez; Darrell J Triulzi; Timothy R Billiar; Matthew D Neal
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

Review 8.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

9.  Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosis.

Authors:  Kasey Davis; Sami Banerjee; Arnaud Friggeri; Celeste Bell; Edward Abraham; Mourad Zerfaoui
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

10.  HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.

Authors:  Jean-Marc Tadie; Hong-Beom Bae; Shaoning Jiang; Dae Won Park; Celeste P Bell; Huan Yang; Jean-Francois Pittet; Kevin Tracey; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.